Why do we get Alzheimer's disease?
Multimedia
·
OSTI ID:987523
Neurodegenerative diseases and Alzheimer's disease (AD) in particular, are among the major health concerns of the elderly in industrialized societies. The cause of AD is unknown and no disease-modifying treatments are available. The disease is characterized clinically by a progressive dementia and pathologically by the accumulation of protein aggregates in the brain and a profound loss of nerve cells. It has also become clear recently that local immune responses are activated in the AD brain and may have a role in the disease. Our laboratory uses genetic mouse models to understand the disease process and to identify potential therapeutic targets.
- Research Organization:
- SLAC (SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States))
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- AC02-76SF00515
- OSTI ID:
- 987523
- Resource Relation:
- Conference: SLAC Public Lecture Series, SLAC National Accelerator Laboratory, Menlo Park, California, presented on October 02, 2006
- Country of Publication:
- United States
- Language:
- English
Similar Records
Why Do We Get Alzheimer's Disease?
MicroRNAs as diagnostic and therapeutic tools for Alzheimer’s disease: advances and limitations
Amelioration of Alzheimer’s disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer’s disease
Multimedia
·
Mon Jan 02 00:00:00 EST 2006
·
OSTI ID:987523
MicroRNAs as diagnostic and therapeutic tools for Alzheimer’s disease: advances and limitations
Journal Article
·
Tue Jan 01 00:00:00 EST 2019
· Neural Regeneration Research
·
OSTI ID:987523
Amelioration of Alzheimer’s disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer’s disease
Journal Article
·
Tue Jan 01 00:00:00 EST 2019
· Neural Regeneration Research
·
OSTI ID:987523